Oura Postpones 2.2 Billion Dollar Nasdaq IPO
Oura postponed its planned initial public offering on the Nasdaq, citing market uncertainty and investor concerns over the company's target valuation.
Health-tracking ring maker Oura postponed its planned initial public offering on the Nasdaq Stock Exchange on Tuesday. The company had intended to raise up to $2.2 billion by selling 50 million shares priced between $40 and $44, which would have valued the firm at approximately $15 billion to $15.62 billion.
Oura cited general uncertainty in the IPO market, including geopolitical tensions, Federal Reserve interest-rate hikes, and rising US debt yields, as primary reasons for the delay. However, separate reports indicate that some potential investors declined to participate due to the proposed valuation and the proportion of existing stock being sold by current shareholders rather than the company raising new capital.
Despite the postponement, the company reports strong financial growth. Oura forecasts a 90 percent revenue increase for fiscal 2026 and has reached 5.7 million paid members following the launch of the Oura Ring 5. CEO Tom Hale stated that the company has the luxury of choosing its moment to go public.
The delay occurs as Oura disputes a class-action lawsuit filed by the Clarkson Law Firm, which alleges the company misled users regarding the accuracy of its sleep tracking data. Oura maintains that the legal action is unrelated to the IPO postponement. The move follows a similar delay by Holtec International.
